ArticleCardio-oncology (London, England)2026

Evaluating the impact of Lutetium-177 therapy on bioprosthetic heart valves in carcinoid heart disease.

Isabel G Scalia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.